Coalition For Hemophilia B Inc
Coalition For Hemophilia B Inc shows strong revenue growth and asset accumulation with 0% officer compensation.
EIN: 133686549 · New York, NY · NTEE: G12 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $3.7M |
| Total Expenses | $1.8M |
| Program Spending | 90% |
| CEO/Top Officer Pay | $3,740,305. |
| Net Assets | $2.2M |
| Transparency Score | 95/100 |
Is Coalition For Hemophilia B Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Coalition For Hemophilia B Inc directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Coalition For Hemophilia B Inc
Coalition For Hemophilia B Inc (EIN: 133686549) is a nonprofit organization based in New York, NY, classified under NTEE code G12. The organization reported total revenue of $3.7M and total assets of $2.8M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Coalition For Hemophilia B Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Coalition For Hemophilia B Inc is a mid-size nonprofit that has been operating for 2 years, with 9 years of IRS 990 filings on record (2009–2021). Revenue has grown at a compound annual rate of 19.0%.
Key Financial Metrics (2021)
From the most recent IRS 990 filing on record:
| Total Revenue | $3.4M |
| Total Expenses | $1.8M |
| Surplus / Deficit | +$1.6M |
| Total Assets | $2.3M |
| Total Liabilities | $87K |
| Net Assets | $2.2M |
| Operating Margin | 45.9% |
| Debt-to-Asset Ratio | 3.8% |
| Months of Reserves | 14.9 months |
Financial Health Grade: A
In 2021, Coalition For Hemophilia B Inc reported a surplus of $1.6M with revenue exceeding expenses, holds 14.9 months of operating reserves (strong position), has a debt-to-asset ratio of 3.8% (very low leverage).
Financial Trends
Over 9 years of filings (2009–2021), Coalition For Hemophilia B Inc's revenue has grown at a compound annual growth rate (CAGR) of 19.0%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2021 | +68.6% | +4.3% | +250.7% |
| 2020 | -22.6% | -29.8% | +62.6% |
| 2019 | +21.6% | +13.2% | +20.5% |
| 2018 | +657.1% | +455.4% | +614.7% |
| 2013 | -33.1% | +16.0% | -71.6% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2024 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Coalition For Hemophilia B Inc with a Mission Score of 95 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 5%
- programs: 90%
- fundraising: 5%
According to IRS 990 filings, Coalition For Hemophilia B Inc allocates its expenses as follows: admin: 5%, programs: 90%, fundraising: 5%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2021)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $1.6M, with revenue exceeding expenses.
- Debt-to-asset ratio: 3.8%.
Executive Compensation Analysis
Executive compensation is consistently reported at 0% across all available filings, indicating that no officers receive salaries from the organization, which is highly unusual for an organization of its size with latest revenue of $3,740,305.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Coalition For Hemophilia B Inc's IRS 990 filings:
- Unusually low liabilities in some years (e.g., $1 in 2019 and 2018) could indicate incomplete reporting or specific accounting practices.
Strengths
The following positive indicators were identified for Coalition For Hemophilia B Inc:
- Strong revenue growth, increasing from $281,964 in 2013 to $3,388,972 in 2021.
- Significant asset accumulation, growing from $46,252 in 2013 to $2,270,780 in 2021.
- Consistent reporting of 0% officer compensation, indicating a strong commitment to mission-focused spending.
- Low liabilities across most filing periods, suggesting prudent financial management.
- Positive net income in most recent years, contributing to asset growth.
Frequently Asked Questions about Coalition For Hemophilia B Inc
Is Coalition For Hemophilia B Inc a legitimate charity?
Coalition For Hemophilia B Inc (EIN: 133686549) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 95/100. It has 9 years of IRS 990 filings on record. Total revenue: $3.7M. 1 red flag identified. 5 strengths noted. Financial health grade: A.
How does Coalition For Hemophilia B Inc spend its money?
Coalition For Hemophilia B Inc directs 90% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Coalition For Hemophilia B Inc tax-deductible?
Coalition For Hemophilia B Inc is registered as a tax-exempt nonprofit (EIN: 133686549). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Coalition For Hemophilia B Inc CEO make?
Coalition For Hemophilia B Inc's highest-compensated officer earns $3,740,305. annually. The organization reported $3.7M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Coalition For Hemophilia B Inc's spending goes to programs?
Coalition For Hemophilia B Inc directs 90% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Coalition For Hemophilia B Inc compare to similar nonprofits?
With a transparency score of 95/100 (Excellent), Coalition For Hemophilia B Inc is above average for NTEE category G12 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Coalition For Hemophilia B Inc located?
Coalition For Hemophilia B Inc is headquartered in New York, New York and files with the IRS under EIN 133686549. It is classified under NTEE code G12.
How many years of IRS 990 filings does Coalition For Hemophilia B Inc have?
Coalition For Hemophilia B Inc has 9 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $3.7M in total revenue.
Is Coalition For Hemophilia B Inc financially stable?
Yes, the organization appears financially stable, demonstrating significant revenue growth from $281,964 in 2013 to $3,388,972 in 2021, and a substantial increase in assets from $46,252 to $2,270,780 over the same period, with low liabilities.
How does the organization manage executive compensation?
The organization consistently reports 0% officer compensation across all available IRS 990 filings, indicating that no officers are paid salaries by the organization.
Has the organization grown over time?
Yes, the organization has experienced significant growth, with revenue increasing from $281,964 in 2013 to $3,388,972 in 2021, and assets growing from $46,252 to $2,270,780 in the same timeframe.
What is the organization's approach to liabilities?
The organization maintains very low liabilities, often reporting $1 or $0 in several periods, suggesting a conservative and responsible approach to financial obligations.
Filing History
IRS 990 filing history for Coalition For Hemophilia B Inc showing financial trends over 9 years of public records:
Over 9 years of IRS 990 filings (2009–2021), Coalition For Hemophilia B Inc's revenue has grown by 704.4%, moving from $421K to $3.4M. Total assets increased by 1122.7% over the same period, from $186K to $2.3M. Total functional expenses rose by 453.1%, from $332K to $1.8M. In its most recent filing year (2021), Coalition For Hemophilia B Inc reported a surplus of $1.6M, with revenue exceeding expenses. The organization holds $87K in liabilities against $2.3M in assets (debt-to-asset ratio: 3.8%), resulting in net assets of $2.2M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2021 | $3.4M | $1.8M | $2.3M | $87K | — | — |
| 2020 | $2.0M | $1.8M | $648K | $18K | — | View 990 |
| 2019 | $2.6M | $2.5M | $398K | $1 | — | View 990 |
| 2018 | $2.1M | $2.2M | $331K | $1 | — | View 990 |
| 2013 | $282K | $399K | $46K | $1 | — | View 990 |
| 2012 | $421K | $344K | $163K | $0 | — | View 990 |
| 2011 | $393K | $313K | $109K | $23K | — | View 990 |
| 2010 | $174K | $330K | $20K | $14K | — | View 990 |
| 2009 | $421K | $332K | $186K | $24K | — | View 990 |
Year-by-Year Financial Summary
- 2021: Revenue of $3.4M, expenses of $1.8M, and assets of $2.3M (revenue +68.6% year-over-year).
- 2020: Revenue of $2.0M, expenses of $1.8M, and assets of $648K (revenue -22.6% year-over-year).
- 2019: Revenue of $2.6M, expenses of $2.5M, and assets of $398K (revenue +21.6% year-over-year).
- 2018: Revenue of $2.1M, expenses of $2.2M, and assets of $331K (revenue +657.1% year-over-year).
- 2013: Revenue of $282K, expenses of $399K, and assets of $46K (revenue -33.1% year-over-year).
- 2012: Revenue of $421K, expenses of $344K, and assets of $163K (revenue +7.2% year-over-year).
- 2011: Revenue of $393K, expenses of $313K, and assets of $109K (revenue +126.2% year-over-year).
- 2010: Revenue of $174K, expenses of $330K, and assets of $20K (revenue -58.8% year-over-year).
- 2009: Revenue of $421K, expenses of $332K, and assets of $186K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Coalition For Hemophilia B Inc:
Data Sources and Methodology
This transparency report for Coalition For Hemophilia B Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.